Drug for treating type II diabetes and complications thereof

A technology for complications and diabetes, which is applied in the field of drugs for the treatment of type 2 diabetes and its complications, can solve the problems of western medicine treatment effect and long treatment cycle, the treatment effect cannot be achieved, and the secondary injury of patients with western medicine, so as to achieve long-lasting effect , significantly lowering effect, blood sugar lowering effect

Active Publication Date: 2015-05-27
LINYI UNIVERSITY +2
View PDF2 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There are many traditional Chinese medicines for the treatment of diabetes and its complications on the market, but their therapeutic effect cannot reach the therapeutic effect of western medicine and the treatment cycle is long. Therefore, in order to eliminate the torment of the disease better and faster, most patients still choose the treatment effect Better western medicine is the first choice for the treatment of this disease, so it is inevitable that while the pain is eliminated, it will cause secondary damage to the patient's body due to the great side effects of western medicine

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Drug for treating type II diabetes and complications thereof
  • Drug for treating type II diabetes and complications thereof
  • Drug for treating type II diabetes and complications thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] The preparation of medicine capsule of the present invention

[0034] Recipe: 200g of Chrysanthemum notoginseng extract, 200g of Lingjuqi extract, 50g of Hongfengcai extract, 100g of Baizicai extract, 50g of Gynostemma pentaphyllum extract, 100g of Cyclocarya paliurus extract, 70g of honeysuckle extract, 230g of excipients . A total of 1250 capsules were made by conventional methods.

[0035] The above auxiliary materials are prepared by mixing 150g of lactose, 60g of starch and 20g of magnesium stearate.

Embodiment 2

[0037] The preparation of medicine soft capsule of the present invention

[0038] Recipe: 280g of Chrysanthemum notoginseng extract, 150g of Lingjuqi extract, 100g of Hongfengcai extract, 70g of Baizicai extract, 70g of Gynostemma pentaphyllum extract, 60g of Cyclocarya paliurus extract, 100g of honeysuckle extract, 170g of excipients . Adopt conventional preparation method to make 1250 soft capsules altogether.

[0039] The above auxiliary materials are prepared by mixing 120g of vegetable oil, 50g of beeswax and 5g of methyl p-hydroxybenzoate.

Embodiment 3

[0041] The preparation of medicine granule of the present invention

[0042] Recipe: Pingwo chrysanthemum notoginseng extract 300g, Lingjuqi extract 170g, red phoenix vegetable extract 80g, white seed vegetable extract 50g, Gynostemma pentaphyllum extract 100g, Cyclocarya paliurus extract 50g, honeysuckle extract 50g, auxiliary materials 200g . It is granulated by conventional dry method and packaged.

[0043] The above auxiliary materials are made by mixing 180g of dextrin and 20g of stevioside.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a drug for treating type II diabetes and complications thereof, belonging to the technical field of traditional Chinese medicines. The drug is composed of the following medicinal raw materials in percentage by weight: 20-30% of gynura procumbens extract, 15-20% of gynura medica extract, 5-10% of edible Gynura extract, 5-10% of gynura divaricata extract, 5-10% of gynostemma pentaphylla extract, 5-10% of cyclocarya paliurus extract, 5-10% of honeysuckle extract, and the balance of auxiliary materials. The drug is prepared from seven pure Chinese herbal medicine extracts as the main raw materials; and therefore, the drug has the advantages of being reasonable in compatibility, obvious in pharmacological effect, low in cost, safe and free from toxic and side effects, and is a good drug for treating type II diabetes and complications thereof.

Description

technical field [0001] The invention relates to a medicine for treating type II diabetes and its complications, which is prepared from Chinese herbal medicine extracts and belongs to the technical field of traditional Chinese medicine. Background technique [0002] Diabetes has become the third major disease that seriously endangers human health after tumors and cardiovascular and cerebrovascular diseases. Data from the World Health Organization and the International Diabetes Federation indicate that the total number of diabetic patients in the world will reach 333 million by 2025. According to the results of diabetes census published in 19 provinces and cities in my country, with the prolongation of the average life expectancy, the increase of economic income and the change of lifestyle (such as eating more and moving less, mental stress, smoking and drinking, etc.), the total number of diabetic patients will increase by at least 100 per year. million increased. In the pas...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/52A61P3/10
Inventor 史晓委周智许彦来张海娟李海刚
Owner LINYI UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products